Ifex Injection, Powder, For Solution
Product Images NDC 0338-3993

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ifex (NDC 0338-3993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ifex Structural Formula (Image 01)

Chemical structure diagram showing the molecular structure of ifosfamide, the active ingredient in IFEX. The structure includes a phosphoramide moiety bonded to a morpholine ring, with chloroethylamine groups attached.*

FDA Label Image

Ifex Container Label (Image 02)

IFEX 1 g vial label for injection, containing ifosfamide powder for intravenous use. The label indicates adding 20 mL sterile water for injection to reconstitute at 50 mg/mL concentration. Manufactured by Baxter Healthcare Corporation, the single-dose vial storage instructions specify controlled room temperature between 20°C to 25°C (68°F to 77°F) and protection from temperatures above 30°C (86°F).*

FDA Label Image

Ifex Carton Label 1 Of 2 (Image 03)

Packaging label for IFEX (ifosfamide for injection, USP) powder for solution injection. The label specifies a single-dose vial containing 1 g of ifosfamide, intended for intravenous use. The product is manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015 USA. The label includes NDC 0338-3991-01 and indicates Rx only.*

FDA Label Image

Ifex Carton Label 2 Of 2 (Image 04)

Packaging label for IFEX (ifosfamide) injection, powder for solution, single-dose vial containing 1 g per vial. The label indicates intravenous use and is produced by Baxter Healthcare Corporation. The label includes directions for reconstitution and storage instructions, as well as NDC 0338-3991-01.*

FDA Label Image

Ifosfamide Container Label (Image 05)

IFEX 3 g injection, powder for solution label for intravenous use. The label indicates the vial contains 3 g of ifosfamide, to be reconstituted with 60 mL sterile water. It is a single-dose vial provided by Baxter Healthcare Corporation. Storage instructions and barcode are also visible.*

FDA Label Image

Ifex Representative Carton Label 0338-3993-01 1 Of 2 (Image 06)

IFEX 3 g vial injection powder for solution, for intravenous use, by Baxter Healthcare Corporation. The label indicates ifosfamide for injection, USP, single dose vial, with a blue 3 g/vial strength circle. The packaging includes NDC 0338-3993-01 and notes the product is Rx only. Manufactured by Baxter Healthcare Corporation, Deerfield, IL.*

FDA Label Image

Ifex Representative Carton Label 0338-3993-01 2 Of 2 (Image 07)

IFEX 3 g vial injection powder label for intravenous use containing ifosfamide. Single dose vial labeled for Rx only, manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, made in Germany. Instructions include adding 60 mL sterile or bacteriostatic water for reconstitution and storage at controlled room temperature 20° to 25°C, protecting from temperatures above 30°C and using reconstituted solutions within 24 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.